CCAAT/Enhancer Binding Protein β Regulates Aromatase Expression via Multiple and Novel Cis-Regulatory Sequences in Uterine Leiomyoma
Open Access
- 1 March 2008
- journal article
- other
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 93 (3) , 981-991
- https://doi.org/10.1210/jc.2007-2507
Abstract
Context: Control of aromatase expression in uterine leiomyoma has significant clinical implications because aromatase inhibitors reduce tumor growth and associated irregular uterine bleeding. The mechanisms that regulate aromatase expression in leiomyoma are unknown. Objectives: We previously demonstrated that the cAMP-responsive proximal promoters I.3 and II regulate aromatase expression in vivo in uterine leiomyoma tissue. Here, we investigated the cellular and molecular mechanisms responsible for promoter I.3/II usage. Results: In smooth muscle cells isolated from leiomyoma (LSMCs), dibutyryl cAMP significantly induced aromatase mRNA and enzyme activity. Reporter constructs of promoter I.3/II deletion and site-directed mutants with selective disruption of cis-regulatory elements in the −517/−16 bp region revealed that five out of seven elements, including three CCAAT/enhancer binding protein (C/EBP) binding sites and two cAMP response elements, were essential for cAMP-induced promoter activity. EMSAs demonstrated that nuclear extracts from LSMCs contain complexes assembled on four of the five cis-elements, with C/EBP binding sites, including a novel −245/−231 bp sequence, clearly associating with C/EBPβ. Chromatin immunoprecipitation assays revealed that C/EBPβ binds specifically to the promoter I.3/II region in intact cells. Dibutyryl cAMP significantly induced nuclear C/EBPβ protein levels in LSMCs in a time-dependent manner. Conversely, knockdown of C/EBPβ dramatically suppressed cAMP-induced aromatase mRNA and enzyme activity. Conclusions: C/EBPβ, which binds to multiple cis-regulatory elements in promoter I.3/II, is a key factor in the transcriptional complex controlling aromatase expression in uterine leiomyoma cells. Definition of this mechanism further may assist in designing inhibitors of aromatase specific for leiomyoma tissue.Keywords
This publication has 41 references indexed in Scilit:
- Prostaglandin E2 Induces Breast Cancer–Related Aromatase Promoters via Activation of p38 and c-Jun NH2-Terminal Kinase in Adipose FibroblastsCancer Research, 2007
- The Effect of Anastrazole on Symptomatic Uterine LeiomyomataObstetrics & Gynecology, 2007
- Prostaglandin E2 increases cyp19 expression in rat granulosa cells: Implication of GATA-4Molecular and Cellular Endocrinology, 2007
- Regulation of C/EBPβ isoforms by MAPK pathways in HL60 cells induced to differentiate by 1,25-dihydroxyvitamin D3Experimental Cell Research, 2006
- A Novel Role of Sodium Butyrate in the Regulation of Cancer-associated Aromatase Promoters I.3 and II by Disrupting a Transcriptional Complex in Breast Adipose FibroblastsPublished by Elsevier ,2006
- CCAAT/Enhancer-Binding Protein Phosphorylation Biases Cortical Precursors to Generate Neurons Rather Than AstrocytesIn VivoJournal of Neuroscience, 2005
- Sequential phosphorylation of CCAAT enhancer-binding protein β by MAPK and glycogen synthase kinase 3β is required for adipogenesisProceedings of the National Academy of Sciences, 2005
- Isolation and Characterization of the Human Syncytin Gene Promoter1Biology of Reproduction, 2004
- Aromatase P450 Gene Expression in Human Adipose Tissue. ROLE OF A Jak/STAT PATHWAY IN REGULATION OF THE ADIPOSE-SPECIFIC PROMOTERPublished by Elsevier ,1995
- Expression of the CYP19 gene and its product aromatase cytochrome P450 in human uterine leiomyoma tissues and cells in cultureJournal of Clinical Endocrinology & Metabolism, 1994